E., Ravuri, C., and Moens, U
Participants with normal hepatic function were eligible for inclusion if they were judged to be of general good health by the investigator, based on a medical examination (including physical examination, medical history, vital signs and ECG) and had liver enzyme levels within prespecified limits (alanine aminotransferase upper limit of normal [ULN] + 10%, aspartate aminotransferase ULN + 20% and total bilirubin ULN + 20%)
All this backs the hypothesis that a GLP-1 RA may shorten the duration of effect for botulinum toxin is biologically plausible
Food and Drug Administration (FDA) recently approved a once-daily oral version of the Wegovy semaglutide, making it the first GLP-1 receptor agonist pill specifically approved for chronic weight management in adults with obesity, or adults who are overweight with at least one weight-related condition
Improved lyophilization conditions for long-term storage of bacteriophages
